AVALO THERAPEUTICS, INC. Shares Outstanding (Cover Page)
AVALO THERAPEUTICS, INC. (AVTX) had Shares Outstanding (Cover Page) of 53.63 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-03: Entity Common Stock, Shares Outstanding 53.63M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 52.57M shares.
- 2026-03-18: Entity Common Stock, Shares Outstanding 22.79M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 18.13M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 53.63M shares 10-Q · filed 2026-08-06 |
| 2026-05-08 | 52.57M shares 10-Q · filed 2026-05-13 |
| 2026-03-18 | 22.79M shares 10-K · filed 2026-03-23 |
| 2025-11-03 | 18.13M shares 10-Q · filed 2025-11-06 |
| 2025-08-06 | 13.15M shares 10-Q · filed 2025-08-07 |
| 2025-05-07 | 10.83M shares 10-Q · filed 2025-05-12 |
| 2025-03-17 | 10.67M shares 10-K · filed 2025-03-20 |
| 2024-11-06 | 10.39M shares 10-Q · filed 2024-11-07 |
| 2024-08-05 | 1.03M shares 10-Q · filed 2024-08-12 |
| 2024-05-08 | 1.03M shares 10-Q/A · filed 2024-07-11 |
| 2024-03-27 | 1.03M shares 10-K · filed 2024-03-29 |
| 2023-11-07 | 192.38M shares 10-Q · filed 2023-11-09 |
| 2023-08-02 | 20.25M shares 10-Q · filed 2023-08-03 |
| 2023-05-01 | 13.20M shares 10-Q · filed 2023-05-04 |
| 2023-03-24 | 13.20M shares 10-K · filed 2023-03-29 |
| 2022-11-03 | 9.41M shares 10-Q · filed 2022-11-07 |
| 2022-08-02 | 9.41M shares 10-Q · filed 2022-08-04 |
| 2022-05-02 | 112.79M shares 10-Q · filed 2022-05-05 |
| 2022-02-28 | 112.79M shares 10-K · filed 2022-03-02 |
| 2021-11-05 | 112.32M shares 10-Q · filed 2021-11-09 |
| 2021-07-30 | 96.01M shares 10-Q · filed 2021-08-02 |
| 2021-05-11 | 95.47M shares 10-Q · filed 2021-05-13 |
| 2021-03-04 | 89.10M shares 10-K · filed 2021-03-08 |
| 2020-11-05 | 74.91M shares 10-Q · filed 2020-11-09 |
| 2020-08-04 | 74.90M shares 10-Q · filed 2020-08-06 |
| 2020-05-04 | 59.61M shares 10-Q · filed 2020-05-07 |
| 2020-03-09 | 57.61M shares 10-K · filed 2020-03-11 |
| 2019-11-12 | 44.11M shares 10-Q · filed 2019-11-14 |
| 2019-08-05 | 42.91M shares 10-Q · filed 2019-08-08 |
| 2019-05-03 | 42.75M shares 10-Q · filed 2019-05-09 |
| 2019-03-11 | 42.65M shares 10-K · filed 2019-03-18 |
| 2018-11-06 | 40.81M shares 10-Q · filed 2018-11-13 |
| 2018-08-06 | 33.84M shares 10-Q · filed 2018-08-09 |
| 2018-05-09 | 31.41M shares 10-Q · filed 2018-05-11 |
| 2018-03-16 | 31.38M shares 10-K · filed 2018-04-02 |
| 2017-11-06 | 26.05M shares 10-Q · filed 2017-11-07 |
| 2017-08-14 | 26.05M shares 10-Q · filed 2017-08-14 |
| 2017-05-09 | 14.08M shares 10-Q · filed 2017-05-09 |
| 2017-03-10 | 10.74M shares 10-K · filed 2017-03-14 |
| 2016-11-01 | 9.26M shares 10-Q · filed 2016-11-08 |
| 2016-08-08 | 8.65M shares 10-Q · filed 2016-08-15 |
| 2016-05-09 | 8.65M shares 10-Q · filed 2016-05-16 |
| 2016-03-16 | 8.65M shares 10-K · filed 2016-03-23 |
| 2015-11-13 | 8.63M shares 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |